Cargando…
Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study
BACKGROUND: Despite optimal neoadjuvant chemotherapy only 40% of gastric cancer tumours achieve complete or partial treatment response. In the absence of treatment response, neoadjuvant chemotherapy in gastric cancer contributes to adverse events without additional survival benefit compared to adjuv...
Autores principales: | Skubleny, Daniel, Lin, Andrea, Garg, Saurabh, McLean, Ross, McCall, Michael, Ghosh, Sunita, Spratlin, Jennifer L, Schiller, Daniel, Rayat, Gina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994053/ https://www.ncbi.nlm.nih.gov/pubmed/36908322 http://dx.doi.org/10.4251/wjgo.v15.i2.303 |
Ejemplares similares
-
Murine and Human Gastric Tissue Establishes Organoids after 48 Hours of Cold Ischemia Time during Shipment
por: Skubleny, Daniel, et al.
Publicado: (2023) -
A prospective Canadian gastroesophageal cancer database: What have we learned?
por: Purich, Kieran, et al.
Publicado: (2023) -
Surface CD200 and CD200R antigens on lymphocytes in advanced gastric cancer: a new potential target for immunotherapy
por: Zgodziński, Witold, et al.
Publicado: (2018) -
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
por: Rathore, Ankita Singh, et al.
Publicado: (2014) -
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)